Consistent with the findings that the homozygous CC genotype of TIMP-1 rs4898 is associated with increased breast cancer risk, the allele C was 55.0% in the patient group, significantly higher than that of 45.0% in the control group (P = 2.41*10-12). Here, TIMP1 is linked to breast carcinoma.